|
English
|
正體中文
|
简体中文
|
0
|
|
???header.visitor??? :
52327966
???header.onlineuser??? :
1037
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"elewski b"???jsp.browse.items-by-author.description???
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2018-09-10T15:28:29Z |
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Results from two randomized, placebo-controlled, phase III trials
|
Papp, K.A.;Menter, M.A.;Abe, M.;Elewski, B.;Feldman, S.R.;Gottlieb, A.B.;Langley, R.;Luger, T.;Thaci, D.;Buonanno, M.;Gupta, P.;Proulx, J.;Lan, S.;Wolk, R.; TSEN-FANG TSAI |
| 國立臺灣大學 |
2014 |
Secukinumab in subjects with moderate-to-severe plaque psoriasis: Results from the Efficacy of Response and Safety of 2 fixed secUkinumab REgimens in psoriasis (ERASURE)
|
Elewski, B.; Lebwohl, M.; Papp, K.; Nakagawa, H.; Sigurgeirsson, B.; Tsai, T. -F.; Tyring, S.; Hampele, I.; Karpov, A.; Helou, S.; Papavassilis, C.; 蔡呈芳 |
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
